Yin Wang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in ⓘ
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 5
-
- Circular RNAs in diseases 9
- RNA modifications and cancer 5
- Mitochondrial Function and Pathology 4
- CRISPR and Genetic Engineering 3
- Advanced biosensing and bioanalysis techniques 3
- RNA and protein synthesis mechanisms 3
- Co-authors
- Farhad R. Danesh (1 shared paper)Paul T. Schumacker (1 shared paper)Benny Hung‐Junn Chang (1 shared paper)Sandra B. Haudek (1 shared paper)Jianyin Long (1 shared paper)JinRong Wang (1 shared paper)Wenjian Wang (1 shared paper)Paul A. Overbeek (1 shared paper)
- Journals
- International Journal of Biological Macromolecules (3 papers)Scientific Reports (2 papers)Molecular Therapy — Oncolytics (2 papers)Acta Biomaterialia (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yin Wang
45 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 301
- Nephrology 127
- Clinical Biochemistry 112
- Molecular Biology 825
- Developmental Neuroscience 27
Countries citing papers authored by Yin Wang
This map shows the geographic impact of Yin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yin Wang more than expected).
Fields of papers citing papers by Yin Wang
This network shows the impact of papers produced by Yin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yin Wang. The network helps show where Yin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 399 | |
| 2 | 2017 | 71 | |
| 3 | 2023 | 69 | |
| 4 | 2021 | 63 | |
| 5 | 2013 | 48 | |
| 6 | 2006 | 44 | |
| 7 | 2020 | 44 | |
| 8 | 2024 | 40 | |
| 9 | 2016 | 34 | |
| 10 | 2013 | 33 | |
| 11 | 2023 | 33 | |
| 12 | 2009 | 30 | |
| 13 | 2014 | 24 | |
| 14 | 2022 | 21 | |
| 15 | 2015 | 20 | |
| 16 | 2022 | 20 | |
| 17 | 2015 | 19 | |
| 18 | 2021 | 19 | |
| 19 | 2021 | 19 | |
| 20 | 2022 | 15 |
About Yin Wang
Yin Wang is a scholar working on Cancer Research, Molecular Biology, Biochemistry, Biological Psychiatry and Biophysics, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include Circular RNAs in diseases (9 papers), MicroRNA in disease regulation (9 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Mitochondrial Function and Pathology (4 papers), CRISPR and Genetic Engineering (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and RNA and protein synthesis mechanisms (3 papers). The work is most often cited by research in Cancer Research (301 citations), Nephrology (127 citations), Clinical Biochemistry (112 citations), Molecular Biology (825 citations) and Developmental Neuroscience (27 citations). Yin Wang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Farhad R. Danesh, Paul T. Schumacker, Benny Hung‐Junn Chang, Sandra B. Haudek, Jianyin Long, JinRong Wang, Wenjian Wang, Paul A. Overbeek, Peifeng Li and Ying Shen. Their work appears in journals such as International Journal of Biological Macromolecules, Scientific Reports, Molecular Therapy — Oncolytics, Acta Biomaterialia and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.